Abstract | BACKGROUND: To date, the lack of potent and selective inhibitors has hampered the physiological assessment of modulation of the cardiac slowly activating delayed rectifier current, I(Ks). The present study, using the I(Ks) blocker L-768,673, represents the first in vivo assessment of the cardiac electrophysiological and antiarrhythmic effects of selective I(Ks) blockade. METHODS AND RESULTS: In an anesthetized canine model of recent (8.5+/-0.4 days) anterior myocardial infarction, 0.003 to 0.03 mg/kg L-768,673 IV significantly suppressed electrically induced ventricular tachyarrhythmias and reduced the incidence of lethal arrhythmias precipitated by acute, thrombotically induced posterolateral myocardial ischemia. Antiarrhythmic protection afforded by L-768,673 was accompanied by modest 7% to 10% increases in noninfarct zone ventricular effective refractory period, 3% to 5% increases in infarct zone ventricular effective refractory period, and 4% to 6% increases in QTc interval. In a conscious canine model of healed (3 to 4 weeks) anterior myocardial infarction, ventricular fibrillation was provoked by transient occlusion of the left circumflex coronary artery during submaximal exercise. Pretreatment with 0.03 mg/kg L-768,673 IV elicited a modest 7% increase in QTc, prevented ventricular fibrillation in 5 of 6 animals, and suppressed arrhythmias in 2 additional animals. CONCLUSIONS: The present findings suggest that selective blockade of I(Ks) may be a potentially useful intervention for the prevention of malignant ischemic ventricular arrhythmias.
|
Authors | J J Lynch Jr, M S Houle, G L Stump, A A Wallace, D B Gilberto, H Jahansouz, G R Smith, A J Tebben, N J Liverton, H G Selnick, D A Claremon, G E Billman |
Journal | Circulation
(Circulation)
Vol. 100
Issue 18
Pg. 1917-22
(Nov 02 1999)
ISSN: 1524-4539 [Electronic] United States |
PMID | 10545437
(Publication Type: Journal Article)
|
Chemical References |
- Acetamides
- Anti-Arrhythmia Agents
- Benzodiazepinones
- L 768673
|
Topics |
- Acetamides
(therapeutic use)
- Animals
- Anti-Arrhythmia Agents
(therapeutic use)
- Arrhythmias, Cardiac
(drug therapy, etiology)
- Benzodiazepinones
(therapeutic use)
- Disease Models, Animal
- Dogs
- Electrocardiography
- Heart Block
(therapy)
- Myocardial Ischemia
(complications, drug therapy)
- Sympathetic Nervous System
(physiology)
- Ventricular Dysfunction
(drug therapy, etiology)
|